Citius pharmaceuticals to be added to russell 3000® and russell 2000® indexes

Cranford, n.j. , june 26, 2023 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products,  today announced that it is set to be added to the broad-market russell 3000® index and the small-cap russell 2000® index at the conclusion of the annual reconstitution of russell us indexes, effective at the opening of the u.s. equity markets on june 26, 2023.
CTXR Ratings Summary
CTXR Quant Ranking